Download to XLS

Document And Entity Information

v2.4.0.6
Document And Entity Information (USD $)
 3 Months Ended
Mar. 31, 2012
Apr. 30, 2012
Jun. 30, 2011
Document and Entity Information [Abstract]      
Entity Registrant Name Applied Nanotech Holdings, Inc    
Document Type 10-Q    
Current Fiscal Year End Date --12-31    
Entity Common Stock, Shares Outstanding   119,137,919  
Entity Public Float     $ 46,685,333
Amendment Flag false    
Entity Central Index Key 0000891417    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Filer Category Smaller Reporting Company    
Entity Well-known Seasoned Issuer No    
Document Period End Date Mar. 31, 2012    
Document Fiscal Year Focus 2012    
Document Fiscal Period Focus Q1    

CONSOLIDATED BALANCE SHEETS

v2.4.0.6
CONSOLIDATED BALANCE SHEETS (USD $)
Mar. 31, 2012
Dec. 31, 2011
Current assets:    
Cash and cash equivalents $ 2,172,935 $ 3,071,783
Accounts receivable, trade – net of allowance for doubtful accounts 550,989 839,863
Prepaid expenses and other current assets 117,970 153,021
Total current assets 2,841,894 4,064,667
Property and equipment, net 352,993 303,055
Other assets 28,591 28,745
Total assets 3,223,478 4,396,467
Current liabilities:    
Accounts payable 486,772 324,333
Convertible notes payable 1,540,782  
Obligations under capital lease 56,084 40,701
Accrued liabilities 421,371 379,675
Deposits and deferred revenue 200,000 200,000
Total current liabilities 2,705,009 944,709
Obligations under capital lease, long-term 52,652 48,559
Convertible notes payable   1,486,510
Total liabilities 2,757,661 2,479,778
Commitments and contingencies      
Stockholders' equity:    
Preferred stock, $1.00 par value, 2,000,000 shares authorized; No shares issued and outstanding      
Common stock, $.00l par value, 160,000,000 shares authorized, 119,137,919 and 118,915,698 shares issued and outstanding at March 31, 2012 and December 31, 2011, respectively 119,138 118,916
Additional paid-in capital 114,810,131 114,654,026
Accumulated deficit (114,463,452) (112,856,253)
Total stockholders' equity 465,817 1,916,689
Total liabilities and stockholders' equity $ 3,223,478 $ 4,396,467

CONSOLIDATED BALANCE SHEETS (Parentheticals)

v2.4.0.6
CONSOLIDATED BALANCE SHEETS (Parentheticals) (USD $)
Mar. 31, 2012
Dec. 31, 2011
Preferred stock par value (in Dollars per share) $ 1.00 $ 1.00
Preferred stock, shares authorized 2,000,000 2,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock par value (in Dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized 160,000,000 160,000,000
Common stock, shares issued 119,137,919 118,915,698
Common stock, shares outstanding 119,137,919 118,915,698

CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.0.6
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
 3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Revenues    
Government contracts $ 416,166 $ 1,251,092
Contract research 67,212 548,790
License fees and royalties 177,300 1,140
Other 116,458 135,959
Total revenues 777,136 1,936,981
Research and development 1,353,266 1,601,734
Selling, general and administrative expenses 942,004 817,555
Operating costs and expenses 2,295,270 2,419,289
Loss from operations (1,518,134) (482,308)
Other income (expense), net    
Interest expense (89,911) (132,431)
Interest income 846 942
Loss before taxes (1,607,199) (613,797)
Provision for taxes      
Net loss $ (1,607,199) $ (613,797)
Loss per share    
Basic and Diluted (in Dollars per share) $ (0.01) $ (0.01)
Weighted average shares outstanding    
Basic and Diluted (in Shares) 119,061,376 110,759,903

CONSOLIDATED STATEMENTS OF CASH FLOWS

v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
 3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Cash flows from operating activities:    
Net loss $ (1,607,199) $ (613,797)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 26,121 14,883
Amortization of discount on debt 54,272 93,211
Stock based compensation expense 96,327 196,360
Changes in assets and liabilities:    
Accounts receivable, trade 288,874 (344,671)
Prepaid expenses and other assets 35,205 (61,708)
Accounts payable and accrued liabilities 264,135 (169,618)
Deposits and deferred revenue   206,910
Total adjustments 764,934 (64,633)
Net cash used in operating activities (842,265) (678,430)
Cash flows from investing activities:    
Capital expenditures (47,492) (8,508)
Net cash used in investing activities (47,492) (8,508)
Cash flows from financing activities:    
Proceeds from issuance of common stock   2,526,314
Repayment of capital lease obligations (9,091) (5,935)
Net cash provided by (used in) financing activities (9,091) 2,520,379
Net increase (decrease) in cash and cash equivalents (898,848) 1,833,441
Cash and cash equivalents, beginning of period 3,071,783 2,732,570
Cash and cash equivalents, end of period $ 2,172,935 $ 4,566,011

1. Basis of Presentation

v2.4.0.6
1. Basis of Presentation
 3 Months Ended
Mar. 31, 2012
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
1.  Basis of Presentation

The consolidated financial statements of the Company for the three-month periods ended March 31, 2012 and 2011, have been prepared by the Company without audit pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of the Company’s management, all adjustments necessary to present fairly the financial position, results of operations, and cash flows of the Company as of March 31, 2012 and 2011, and for the periods then ended, have been made. Those adjustments consist of normal and recurring adjustments. The consolidated balance sheet of the Company as of December 31, 2011, has been derived from the audited consolidated balance sheet of the Company as of that date.

Certain information and note disclosures normally included in the Company’s annual financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted. These consolidated financial statements should be read in conjunction with a reading of the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2011, as filed with the Securities and Exchange Commission.

The results of operations for the three-month period ended March 31, 2012, are not necessarily indicative of the results to be expected for the full year.

2. Supplemental Cash Flow Information

v2.4.0.6
2. Supplemental Cash Flow Information
 3 Months Ended
Mar. 31, 2012
Cash Flow, Supplemental Disclosures [Text Block]
2.  Supplemental Cash Flow Information

Cash paid for interest for the three months ended March 31, 2012 and 2011, was $3,323 and $987, respectively. During the three months ended March 31, 2012 and 2011, the Company had non-cash transactions related to share based payments described in greater detail in Note 5, non-cash transactions related to the conversion of accounts payable into common stock described in greater detail in Note 4, and non-cash transactions related to the conversion of notes payable and related accrued interest into common stock that are described in greater detail in Note 3. The Company also had a capital lease transaction in the amount of $28,567 in the three months ended March 31, 2012.

3. Notes Payable and Long-Term Debt

v2.4.0.6
3. Notes Payable and Long-Term Debt
 3 Months Ended
Mar. 31, 2012
Debt Disclosure [Text Block]
3.  Notes Payable and Long-Term Debt

We issued convertible notes payable in 2009 and 2010. These notes bear interest at a rate of 8% and are due in 2012. The notes and resulting accrued interest are convertible into shares of our common stock at rates of $0.20 to $0.25 per share. The face amount of the notes due was $2,146,000, and we valued the conversion rights at $647,250, which was recorded as a discount at the time of issuance. This discount is being amortized to interest expense over the term of the note. $216,000 of these notes were issued to officers and directors of the Company. As of March 31, 2012, a total of $526,000 of these notes have been converted to common stock, leaving a remaining principal balance as of that date of $1,620,000. A total of $79,218 of unamortized discount remains to be amortized in future periods. During the quarter ended March 31, 2011, a total of $317,000 of principal and related accrued interest of $30,607 was converted into 1,724,996 shares of common stock. No notes were converted in the quarter ended March 31, 2012.

4. Stockholders' Equity

v2.4.0.6
4. Stockholders' Equity
 3 Months Ended
Mar. 31, 2012
Stockholders' Equity Note Disclosure [Text Block]
4.  Stockholders’ Equity

During the three months ended March 31, 2011, we issued 6,578,948 restricted shares of common stock and received proceeds of $2.5 million in an exempt offering under Regulation D of the Securities Act of 1933, and 107,587 shares for total proceeds of $26,314 in connection with the exercise of options by former employees. We also issued 157,895 shares of restricted common stock in payment of accounts payable in the amount of $60,000 during the same period, as well as 103,722 shares in connection with restricted stock payments to employees.  During the three months ended March 31, 2012, we issued 222,222 restricted shares of common stock related to the payment of $60,000 of trade payables  in an exempt offering under Regulation D of the Securities Act of 1933.   

5. Share-Based Payments

v2.4.0.6
5. Share-Based Payments
 3 Months Ended
Mar. 31, 2012
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]
5.  Share-Based Payments

We use the fair value method to account for stock based compensation. We recorded $96,327 and $196,360 in compensation expense in the periods ended March 31, 2012 and 2011, respectively, related to options and restricted stock issued under our stock-based incentive compensation plans. This includes expense related to both options issued and committed, as well as unissued restricted stock  in the current year, and options issued in prior years for which the requisite service period for those options includes the current year. The fair value of these options was calculated using the Black-Scholes option pricing model. Information related to the assumptions used in this model is set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2011. For options issued in 2012, the same approximate assumptions were used.

6. Contingencies

v2.4.0.6
6. Contingencies
 3 Months Ended
Mar. 31, 2012
Commitments and Contingencies Disclosure [Text Block]
6.  Contingencies

Litigation

The Company is a defendant in minor lawsuits described in greater detail in its 2011 annual report on Form 10-K. The Company expects any potential eventual payment to have no material affect on the financial statements.